Paula Cloghessy
Nessuna posizione attualmente
Patrimonio netto: 33 075 $ in data 30/06/2024
Provenienza dei contatti di primo grado di Paula Cloghessy
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Biotechnology | 22 | |
Joule Unlimited Technologies, Inc.
 Joule Unlimited Technologies, Inc. Industrial SpecialtiesProcess Industries Joule Unlimited Technologies, Inc. produces renewable fuels and chemicals. It offers a technology platform for liquid fuel from the Sun. The company was founded by Noubar B. Afeyan in 2007 and is headquartered in Bedford, MA.
13
| Extinct | Industrial Specialties | 13 |
| Public Company | Biotechnology | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Paula Cloghessy tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NORSK HYDRO ASA | Aluminum | Corporate Officer/Principal | |
| EISAI CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Human Resources Officer Corporate Officer/Principal | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| DNIB UNWIND INC | Biotechnology | Chairman Corporate Officer/Principal | |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member | |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Virginia | College/University | Corporate Officer/Principal Graduate Degree | |
| Boston University | College/University | Undergraduate Degree Doctorate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering, Inc. (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
| INSEAD | College/University | Undergraduate Degree Masters Business Admin | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Worcester Polytechnic Institute | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Private Equity Investor | |
| Norwegian School of Economics & Business Administration | College/University | Graduate Degree Graduate Degree | |
Boston Philharmonic Orchestra
 Boston Philharmonic Orchestra Movies/EntertainmentConsumer Services Boston Philharmonic Orchestra is a semi-professional orchestra. The company was founded by Benjamin Zander in 1979 and is headquartered in Boston, MA. | Movies/Entertainment | Director/Board Member | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| T2 BIOSYSTEMS, INC. | Medical Specialties | Founder | |
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree | |
The Russian Union of Industrialists & Entrepreneurs
 The Russian Union of Industrialists & Entrepreneurs Miscellaneous Commercial ServicesCommercial Services The Russian Union of Industrialists & Entrepreneurs operates as a non-political organization to protect the interests of industry. The company is based in Moscow, Russian Federation and has subsidiaries in the Russian Federation. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Agrinos AS
 Agrinos AS Chemicals: AgriculturalProcess Industries Agrinos AS engages in the development, production, and trade of biological crop inputs. Its products include iNvigorate, B-Sure, and Agrinos 5-0-0. The firm focuses on core crops such as corn, potatoes, soybeans, sugarcanes, tomatoes, and wheat; and regional crops such as verries, citrus and fruit trees, coffee, cotton, forage, leafy greens, and vegetables. The company was founded by Kjetil Langland Bøhn, Karl Reiner Fick Rochin, and Aaron Powers in 2009 and is headquartered in Oslo, Norway. | Chemicals: Agricultural | Chief Executive Officer Chief Executive Officer | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director/Board Member Director/Board Member | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Founder Director/Board Member Corporate Officer/Principal | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder | |
| NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| IKENA ONCOLOGY, INC. | Biotechnology | Chairman Director/Board Member Chairman Director/Board Member | |
Institute For Genome Sciences
 Institute For Genome Sciences BiotechnologyHealth Technology The Institute for Genome Sciences provides research and development services for microbiologists. The private company is based in Baltimore. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Osler Diagnostics Ltd.
 Osler Diagnostics Ltd. BiotechnologyHealth Technology Osler Diagnostics Ltd. engages in research and development in biotechnology. The company was founded by Jason Davis and Paulo R. Bueno and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
Longevity Vision Fund
 Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund (Longevity Vision Fund) is a venture capital firm founded in 2018 by Sergey Young. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Upstream Bio, Inc.
 Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Vivere Lifesciences Acquisition Corp.
 Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Financial Conglomerates | Corporate Officer/Principal | |
Slate Bio, Inc.
 Slate Bio, Inc. BiotechnologyHealth Technology Slate Bio, Inc. is a pre-clinical stage biotechnology company that focuses on developing therapies to restore the body's natural immunological response in various diseases. The company is based in Charlottesville, VA. The company's lead compound is a bifunctional IL233 cytokine that augments Tregs and expands tissue resident Tregs. The CEO of the company is Andrew J. Krouse. | Biotechnology | Director/Board Member | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Chairman |
Statistiche
Distribuzione geografica
| Stati Uniti | 42 |
| Norvegia | 4 |
| Giappone | 2 |
| Francia | 2 |
| Russia | 2 |
Settori
| Health Technology | 31 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 5 |
| Non-Energy Minerals | 2 |
Posizioni
| Director/Board Member | 221 |
| Corporate Officer/Principal | 93 |
| Independent Dir/Board Member | 69 |
| Chairman | 52 |
| Founder | 44 |
Contatti più connessi
| Insiders | |
|---|---|
| Jean-Francois Formela | 48 |
| Daniel Lynch | 32 |
| David Berry | 31 |
| Anatoliy Borisovich Chubays | 29 |
| Caroline Dorsa | 27 |
| Ruben Karlenovich Vardanian | 26 |
| Ronald Renaud | 24 |
| Owen Hughes | 23 |
| Brian Gallagher | 21 |
| Grégory Behar | 20 |
| Raffi Mardirosian | 18 |
| Claire Fraser-Liggett | 13 |
| Robert Meyer | 13 |
| George Demetri | 12 |
| E. Sutherland | 12 |
- Borsa valori
- Insiders
- Paula Cloghessy
- Connessioni Società
